Imazodan
| Title | Journal |
|---|---|
| Defining the binding site of levosimendan and its analogues in a regulatory cardiac troponin C-troponin I complex. | Biochemistry 20080715 |
| Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model. | Journal of biomolecular screening 20060801 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Mechanisms of leptin secretion from white adipocytes. | American journal of physiology. Cell physiology 20020701 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties. | Journal of cardiovascular pharmacology 19930601 |
| 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase. | Journal of medicinal chemistry 19920221 |
| Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure. | Journal of medicinal chemistry 19890201 |